These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29325280)

  • 21. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
    Gregorio GV; McFarlane B; Bracken P; Vergani D; Mieli-Vergani G
    Autoimmunity; 2002 Dec; 35(8):515-9. PubMed ID: 12765477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
    Löhr HF; Schlaak JF; Lohse AW; Böcher WO; Arenz M; Gerken G; Meyer Zum Büschenfelde KH
    Hepatology; 1996 Dec; 24(6):1416-21. PubMed ID: 8938173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 24. Seronegative autoimmune hepatitis in children: a single-center experience.
    Islek A; Keskin H
    Acta Gastroenterol Belg; 2021; 84(2):305-310. PubMed ID: 34217180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis.
    Strassburg CP; Obermayer-Straub P; Alex B; Durazzo M; Rizzetto M; Tukey RH; Manns MP
    Gastroenterology; 1996 Dec; 111(6):1576-86. PubMed ID: 8942737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis.
    Engel B; Diestelhorst J; Hupa-Breier KL; Kirchner T; Henjes N; Loges S; Yuksel M; Janczyk W; Lalanne C; Zachou K; Oo YH; Gournay J; Pape S; Drenth JPH; Renand A; Dalekos GN; Muratori L; Socha P; Ma Y; Arikan C; Baumann U; Manns MP; Wedemeyer H; Junge N; Jaeckel E; Taubert R
    Hepatol Int; 2024 Aug; 18(4):1214-1226. PubMed ID: 38976227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features of autoimmune hepatitis patients with poor response to treatment].
    Zhang HW; Liu HM; Lin R; Zhou L; Zhang J; Liu WT
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):755-759. PubMed ID: 29108204
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic criteria of autoimmune hepatitis.
    Liberal R; Grant CR; Longhi MS; Mieli-Vergani G; Vergani D
    Autoimmun Rev; 2014; 13(4-5):435-40. PubMed ID: 24418295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease.
    Han S; Tredger M; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1995 Jan; 21(1):58-62. PubMed ID: 7806169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1.
    Iijima Y; Kato T; Miyakawa H; Ogino M; Mizuno M; Sugihara K; Ando T; Fujiwara K; Orito E; Ueda R; Mizokami M
    J Gastroenterol Hepatol; 2001 Jul; 16(7):782-8. PubMed ID: 11446887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver kidney microsome antibodies. Analysis of a laboratory series.
    Sanchez S; Fang D; Xiao S; Rezavi LA; Howard BM; Caturegli P; Cihakova D
    Pract Lab Med; 2023 Jan; 33():e00307. PubMed ID: 36660178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
    Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
    Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis.
    Toda G; Zeniya M; Watanabe F; Imawari M; Kiyosawa K; Nishioka M; Tsuji T; Omata M
    J Hepatol; 1997 Jun; 26(6):1207-12. PubMed ID: 9210605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
    Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
    Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
    J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Significance of Autoantibodies in Children With Acute Liver Failure.
    Narkewicz MR; Horslen S; Belle SH; Rudnick DA; Ng VL; Rosenthal P; Romero R; Loomes KM; Zhang S; Hardison RM; Squires RH;
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):210-217. PubMed ID: 27496798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell receptor Vbeta chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients.
    Arenz M; Pingel S; Schirmacher P; Meyer zum Büschenfelde KH; Löhr HF
    Liver; 2001 Feb; 21(1):18-25. PubMed ID: 11169068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of frequency of autoimmune hepatitis autoantibodies in children with type 1 diabetes.
    Honar N; Karamizadeh Z; Vazirian MV; Jahanshahi K; Manouchehri A; Dehghani SM; Javaherizadeh H
    Rev Gastroenterol Peru; 2019; 39(4):344-347. PubMed ID: 32097394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
    Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
    Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.